Tag: Ontario

  • Brain Star Award winner feature: Diego B. Piza, Western University, won this prize based on the excellence of the research and its potential benefits to the health of Canadians. Brain Star Awards are presented by the Canadian Association for Neuroscience (CAN) and the Canadian Institutes of Health’s Institute of Neurosciences, Mental Health and Addiction

    The hippocampus is a structure of the mammalian brain that has been implicated in spatial memory and navigation. Its role has been primarily studied in nocturnal mammals, such as rats, that lack many adaptations for daylight vision. Here, Diego B. Piza, working in the laboratory of Julio Martinez-Trujillo at Western University, demonstrates that during 3D navigation, the common marmoset, a New World primate adapted to daylight, uses different exploration–navigation strategies compared to rats. He further shows that maps of space in the marmoset brain depend on vision-related cues and object relationships used as landmarks for navigation. It is likely that similar encoding mechanisms exist in other diurnal mammals, including humans.

    To explore their environment, marmosets predominantly use rapid head-gaze shifts for visual exploration while remaining stationary. During active movement, marmosets stabilize their head, in contrast to rats, who use low-speed head movements to scan the environment as they locomote. This work suggests that spatial memory in primates may rely on anchoring sequences of views to specific places, providing a unique mechanism for encoding spatial experiences.

    This publication represents a major technical and conceptual achievement in neuroscience.

    Read the full story: https://can-acn.org/brain-star-award-winner-diego-b-piza/

    Article citation

    Piza, D.B., Corrigan, B.W., Gulli, R.A., Do Carmo, S., Cuello, A.C., Muller, L., Martinez-Trujillo, J. Primacy of vision shapes behavioral strategies and neural substrates of spatial navigation in marmoset hippocampus. Nat Commun 15, 4053 (2024). https://doi.org/10.1038/s41467-024-48374-2

    https://doi.org/10.1038/s41467-024-48374-2


  • Brain Star Award Feature: Andrew Mocle, University of Toronto, won this prize based on the excellence of the research and its potential benefits to the health of Canadians. Brain Star Awards are presented by the Canadian Association for Neuroscience (CAN) and the Canadian Institutes of Health’s Institute of Neurosciences, Mental Health and Addiction

    The hippocampus is a critical brain region for encoding and recall of episodic memories. The physical trace left in the brain by memory formation is called an ‘engram’, and the process by which new engrams are formed is still unclear. In this work, Andrew Mocle, working in the laboratory of Sheena Josselyn, used advanced imaging techniques to track neurons and their patterns of activity before, during, and after memory encoding. The resulting data prompted a new engram formation model, whereby small ensembles of neurons (instead of individual cells) are allocated to an engram depending on their average excitability at the time of learning. The demonstration that highly-excitable ensembles are preferentially allocated to encode newly learned information represents a major conceptual advance in the study of how memories are stored in the brain.

    Read more: https://can-acn.org/brain-star-award-winner-andrew-mocle/

    Featured scientific publication: Mocle, Andrew J., Adam I. Ramsaran, Alexander D. Jacob, Asim J. Rashid, Alessandro Luchetti, Lina M. Tran, Blake A. Richards, Paul W. Frankland, and Sheena A. Josselyn. “Excitability Mediates Allocation of Pre-Configured Ensembles to a Hippocampal Engram Supporting Contextual Conditioned Threat in Mice.” Neuron 112, no. 9 (May 1, 2024): 1487-1497.e6.

    https://doi.org/10.1016/j.neuron.2024.02.007


  • Brain Star Award Feature: Caroline Nettekoven, Western University, won this prize based on the excellence of the research and its potential benefits to the health of Canadians. Brain Star Awards are presented by the Canadian Association for Neuroscience (CAN) and the Canadian Institutes of Health’s Institute of Neurosciences, Mental Health and Addiction

    The human cerebellum is a brain region that is activated during many behaviours, including movement, language and cognitive tasks. However, the cerebellum’s contribution to these processes remained poorly understood because of a lack of a comprehensive functional map of this brain region. To address this, Caroline Nettekoven, working in the laboratory of Jorn Diedrichsen at Western University, fused 7 large-scale brain activity imaging (fMRI) datasets into the first comprehensive functional atlas of the cerebellum. The authors developed a computational model that learns brain organization across many datasets and derived a consensus atlas based on 111 subjects and 417 task conditions. This new atlas predicts functional boundaries better than previous atlases and any atlas based on a single dataset only – even on new, unseen data. It therefore provides the most detailed characterization of the functional organization of the human cerebellum so far.

    The new atlas provides several novel important features. For example, the atlas and the computational model are designed for precision functional mapping in individuals. Existing atlases simply present a group map, ignoring the large inter-individual variability of functional organisation. The model can integrate the new atlas with a short 10-minute localizer scan to adapt to an individual’s brain, resulting in a much better prediction of individual boundaries. This unprecedented precision will enable detailed investigations into the cerebellum’s contribution to human behaviour.

    Read the full story here

    Scientific publication

    Caroline Nettekoven , Da Zhi, Ladan Shahshahani , Ana Luísa Pinho, Noam Saadon-Grosman, Randy Lee Buckner, Jörn Diedrichsen A hierarchical atlas of the human cerebellum for functional precision mapping. Nat Commun 15, 8376 (2024). https://doi.org/10.1038/s41467-024-52371-w

    https://doi.org/https://doi.org/10.1038/s41467-024-52371-w

    https://rdcu.be/dViIJ


  • This is a Brain Star Award feature: Hayley Renee Christine Shanks, Western University, won this prize based on the excellence of the research and its potential benefits to the health of Canadians. Brain Star Awards are presented by the Canadian Association for Neuroscience (CAN) and the Canadian Institutes of Health’s Institute of Neurosciences, Mental Health and Addiction

    Alzheimer’s disease (AD) is a debilitating neurodegenerative disorder for which there is no cure. Therapeutics available to the approximately 734,000 Canadians living with AD provide symptom management without slowing disease progression. Hayley Renee Christine Shanks, working in the laboratory of Dr. Taylor Schmitz at Western University, adopted a novel approach to AD therapeutics by targeting “deep biology” — that is, receptors that control multiple fundamental cellular pathways and may therefore normalize multiple pathological processes underlying AD. This “deep biology” target, called the p75 neurotrophin receptor (p75NTR), plays a critical role in determining  whether cells degenerate or survive. This receptor was discovered approximately 30 years ago and is widely studied in the fields of developmental neuroscience and neurology.

    In AD, p75NTR is a key receptor that mediates neuronal dysfunction, neurodegeneration, and glial reactivity. Research in AD mouse models indicates that modulation of p75NTR with a small molecule called LM11A-31 promotes neuronal resilience and reduces neuroinflammation. Building on this work, Shanks et al. (2024), Nature Medicine, was the first publication to examine selective modulation of p75NTR in individuals with AD.

    Read the full story here: https://can-acn.org/brain-star-award-winner-hayley-renee-christine-shanks/

    Read the original research article here:

    Shanks, HRC, Chen, K, Reiman, EM, Blennow, K, Cummings, JL, Massa, SM, Longo, FM, Börjesson-Hanson, A, Windisch, M, Schmitz, TW. p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nat Med 30, 1761–1770 (2024).  https://doi.org/10.1038/s41591-024-02977-w

    https://www.nature.com/articles/s41591-024-02977-w


  • Findings support precision approaches to hormone therapy for women in midlife and beyond

    Source: CAMH News

    Estradiol, the most common form of the estrogens used in hormone therapy, may influence different types of memory during the menopausal transition and beyond depending on how it is delivered – through the skin or orally – according to new research led by Dr. Liisa Galea, senior scientist and womenmind Treliving Family Chair in Women’s Mental Health at the Centre for Addiction and Mental Health (CAMH). Published today in the journal Neurology, the study is the first to show that the same hormone can have distinct cognitive effects depending on delivery method – highlighting the need for more personalized approaches to women’s brain health. 

    “This is the first study to show that estradiol’s effects on memory vary depending on how it is delivered,” said Dr. Galea. “It also reinforces that cognition is multifaceted, and hormone therapy should be tailored to each woman’s health profile and menopause experience.”

    The study analyzed data from 7,251 cognitively healthy postmenopausal participants using data from the Canadian Longitudinal Study on Aging, a national research project following Canadians over 20 years to understand how different factors affect health and aging. Participants completed tests measuring episodic memory (recalling past events), prospective memory (remembering to perform future tasks) and executive function (planning and problem-solving). Among participants, 4 per cent used transdermal estradiol (delivered through the skin via patches, gels, or vaginal applications), 2 per cent used oral estradiol pills, and 94 per cent did not use hormone therapy. 

    The researchers found that the earlier someone experienced menopause, the more it affected cognition across all the areas tested. Transdermal estradiol users demonstrated better episodic memory compared to non-users, while oral estradiol users showed improved prospective memory. This suggests that estradiol’s delivery method impacts different aspects of cognition. Hormone therapy did not appear to affect executive function in either case, and all findings were consistent regardless of the number of children participants had or their genetic risk factors. Notably, estradiol therapy was never associated with poorer cognitive outcomes, reaffirming its potential positive value for women’s brain health in menopause. 

    Dr. Galea added: “There’s clearly a lot more we need to understand about how different estrogens can support the brain health of older women. To truly personalize care, we need a better sense of when, how, and for whom it is optimal to use these hormones to support memory. This will be a key area of future exploration.”

    She also emphasized the lack of investment in women’s brain health research. “Only six to seven per cent of health research grants from Canada’s largest health granting agency address women’s health issues but mostly focused on pregnancy — with just 0.18 per cent across 15 years on menopause,” she said. “Women’s brain health remains understudied, underfunded, and overgeneralized. We urgently need more evidence to support women in midlife and beyond. That is why I am thrilled that, with new funding from Wellcome Leap, we are developing an Alzheimer’s disease prediction tool specifically for women, leveraging machine learning and big data.” 

    About the Centre for Addiction and Mental Health (CAMH) 

    The Centre for Addiction and Mental Health (CAMH) is Canada’s largest mental health and addiction teaching hospital and a world leading research centre in this field. CAMH combines clinical care, research, education, policy development and health promotion to help transform the lives of people affected by mental illness and addiction. CAMH is fully affiliated with the University of Toronto and is a Pan American Health Organization/World Health Organization Collaborating Centre. For more information, please visit camh.ca 
    or follow @CAMHnews on Bluesky and LinkedIn. 

    Media Contact: 
    media@camh.ca 


  • The international research team’s ambitious work has implications across multiple fields and sheds compelling new light on the extraordinarily complex serotonin system.

    In our day-to-day lives, we’re constantly making a slew of decisions from immediate matters to prospects on the far horizon. But the evolutionary nuts-and-bolts of how our brains weigh these numerous daily decisions and what role is played by the neurotransmitter serotonin has been shrouded in mystery.

    Now, a new study led by an interdisciplinary uOttawa Faculty of Medicine team delivers fascinating findings on this big topic and potentially unravels a hidden aspect of what our nervous system’s complex serotonin system is really doing inside the enigmatic organ in our skulls.

    (more…)

  • Source of text: David McFadden, Communications Advisor & Research Writer, University of Ottawa

    The study’s findings could potentially help develop targeted therapeutics for mood disorders like major depressive disorder.

    Our lives are filled with binary decisions – choices between one of two alternatives. But what’s really happening inside our brains when we engage in this kind of decision making?

    uOttawa Faculty of Medicine-led study published in Nature Neuroscience sheds new light on these big questions, illuminating a general principle of neural processing in a mysterious region of the midbrain that is the very origin of our central serotonin (5-HT) system, a key part of the nervous system involved in a remarkable range of cognitive and behavioral functions.

    “The current dominating model is that individual 5-HT neurons are acting independently one from another. While it had previously been suggested that 5-HT neurons may rather be connected with one another, it had not been directly demonstrated. That is what we did here. We also identify an intriguing processing role – or a computation – that is supported by this particular type of connectivity between 5-HT neurons,” says Dr. Jean-Claude Béïque, full professor in the Faculty’s Department of Cellular and Molecular Medicine and co-director of the uOttawa Brain and Mind Research Institute’s Centre for Neural Dynamics and Artificial Intelligence.

    The international research team’s work involved a mixture of several experimental approaches such as electrophysiology, cellular imaging, optogenetics and behavioral approaches, along with mathematical modeling and computer simulations.

    Forging advances

    So what does it mean that serotonin neurons clustered together in the brainstem are not independent actors largely keeping to themselves but are actually sending axons to the rest of the brain?

    “In my view, the paper’s main takeaway is that the mammalian serotonin system is far more anatomically and functionally complex than what we previously imagined. This is knowledge that could potentially help develop targeted therapeutics for mood disorders like major depressive disorder,” says Dr. Michael Lynn, the study’s first author and a former member of Dr. Béïque’s Faculty of Medicine lab.

    Dr. Lynn received his PhD in Neuroscience from the University of Ottawa in October 2023. He’s now working as a postdoctoral fellow at the University of Oxford, in the Department of Physiology, Anatomy and Genetics.

    He says the team’s findings are important because it turns out that there are distinct groups of serotonin neurons with their own activity patterns, each controlling serotonin release in a particular region of the brain. This has implications for the “winner-takes-all” principle of neuroscience – an idea applied in computational models of neural networks in which neurons essentially compete to get activated.

    “The new principles uncovered in this paper suggest that these distinct ensembles can interact in some scenarios: ‘winning’ serotonin ensembles with high activity can strongly reduce serotonin release from ‘losing’ serotonin ensembles with lower activity levels,” he says. “These imply a more complex, dynamic set of rules about how and when serotonin is released throughout the brain, contrasting with an older view of a more monolithic signal.”

    Decisions, decisions

    The research team’s work has implications for how our brain – an organ with profoundly intricate wiring of neurons with multitudes of enmeshed connections – is involved in day-to-day decision making.

    They determined how the lateral habenula, a region that is activated when we are frustrated and that is implicated in major depression, ultimately controls the activity of serotonin neurons. Habenular neurons are also believed to encode the level of threat that is perceived from a particular environment, or perhaps even from our actions.

    Dr. Béïque explains it like this: “Do we jump from the high diving board at the pool? Or only from the low one? Do we walk down that very dark alley, or do we avoid it?  When is dark too dark?  Somehow our brain must compute features of our world – including how threatening a particular environment is – and come up with a binary output: you go, or you don’t.”

    “We think we have identified a circuit that participates in that very computation that guides our everyday decisions,” he says.

    Next steps

    What’s next for the research team as they build on the advances they have forged over several years with this methodical, innovative examination of the serotonin system? They aim to focus on behavioral studies with mouse models.

    “At this point, the behavioral manifestations of the computation we discovered were somewhat artificial behavior. We’re currently trying to see if we can see similar things when mice are behaving in more naturalistic environments,” Dr. Béïque says.

    The talent-rich research team for the new Nature Neuroscience paper included the uOttawa Faculty of Medicine’sDr. Richard Naud, a computational neuroscientist who was the senior author on a recent serotonin-related study published in Nature, and Sean Geddes, director of Innovation and Partnerships at uOttawa.


  • Almost half Canadian dementia cases influenced by 12 lifestyle factors

    By Debora Van Brenk, St. Joseph’s Healthcare London, Special to Western News, December 12, 2024

    Many people could greatly improve their odds against developing dementia by making four, low-cost lifestyle changes, Western researchers have discovered.

    In the first study of its kind, researchers at Lawson Research Institute (Lawson) and Schulich School of Medicine & Dentistry found about half of dementia cases in Canada can be influenced by 12 lifestyle factors.

    These twelve potential modifiable factors (based on a study of 30,000 Canadians over the age of 45), weighted from most significant factor to least were:

    1. Physical inactivity
    2. Hearing loss
    3. Obesity
    4. Hypertension
    5. Traumatic brain injury
    6. Depression
    7. Less education in early life
    8. Sleep disturbances
    9. Diabetes
    10. Smoking
    11. Excessive alcohol
    12. Social isolation

    Topping the “dirty dozen” list across Canadians’ lifespans, and especially notable from mid-life onwards, are physical inactivity, hearing loss, obesity and hypertension.

    The solutions

    • Get off the couch and get moving
    • Tackle hearing loss early
    • Lose weight
    • Get assessed and treated for high blood pressure

    “While lifestyle changes aren’t a magic pill to prevent all dementias, they’re an empowering way to reduce the overall risk.” – Surim Son, study lead author and PhD candidate at Schulich Medicine & Dentistry and Lawson

    “We’re talking about significant benefits to Canadian health and health systems,” Son, who works with the dementia research program at St. Joseph’s Health Care London, added.

    Read the full article on the Western News website here: https://news.westernu.ca/2024/12/dementia-lifestyle-changes/

    The scientific research article is available in open access:

    Son, S., Speechley, M., Zou, G.Y. et al. Potentially Modifiable Dementia Risk Factors in Canada: An Analysis of Canadian Longitudinal Study on Aging with a Multi-Country Comparison. J Prev Alzheimers Dis 11, 1490–1499 (2024). https://doi.org/10.14283/jpad.2024.105


  • The Amazing Brain Science Talks is an annual event hosted by Healthy Brains, Healthy Lives (HBHL), an interdisciplinary neuroscience program at McGill University. Presented in collaboration with Brain Canada, this event is an opportunity to learn about the latest advances in brain health research in an accessible and engaging format. Join us this year to learn about memory and the aging brain, the impact of cannabis on the developing brain, the role of eye contact in conversations, neurodiversity and more through short, engaging talks by Canadian brain health experts and speakers with lived experience.

    Learn more about this annual event here: https://amazingbrain.ca


  • Dr. Mohamed Abdelhack, Centre for Addiction and Mental Health, was awarded a Brain star award for this work

    Sleep and depression have a complex birectional relationship. For example, while most people suffering from depression also suffer from insomnia, others report hypersomnia. Contradictory results are also seen in scientific studies of this relationship. A new study by Mohamed Abdelhack and colleagues analyzed how brain signals change with differences in sleep habits, depression symptoms, and cognitive abilities in over 30,000 people. By performing such large scale and comprehensive analyses, they reveal opposing relationships between change in brain signals when a person is doing a task and when they are not (resting state). These results provide important insights into the relationship between depressive symptoms and sleep in the general population.

    By analysis data from over 30,000 participants from UK-Biobank and Human Connectome Project, the researchers found contradictions in brain-wide associations of sleep and depression depending on participant’s state. The researchers found brain regions were hyperconnected under resting conditions with insomnia and depression. These results indicate that, in insomnia and depression, resting-state dynamics are resembling those of rested-wakefulness. The brain is signalling a lack of need for sleep which could signal hyperarousal.

    When the researcher analysed data from people while they were performing a task, they instead observed a drop in connection between brain regions, which could be signifying a “local sleep” phase which decreases the cognitive performance as the brain is unable to recruit its resources to perform the task.

    This publication shows counterintuitive results where neural signatures of sleep and depression when the participant was doing a task contradicted those when the participant was not doing any task (resting state). It highlights the importance of probing the effect of mental health in different conditions. These results could also guide advances in clinical practice to investigate more details of sleep habits to optimize care plans while also tracking the cognitive load of patients to assess treatment efficacy.

    About Dr. Mohamed Abdelhack

    Mohamed is a Postdoctoral Fellow at the Whole Person and Population Modelling laboratory at the Krembil Centre for Neuroinformatics working on using statistical analysis of big data and machine/deep learning to model mental health and psychiatric disorders. He mainly uses fMRI imaging, statistical data analysis, and computational modelling.

    He previously worked as a Postdoctoral Researcher in Washington University in St. Louis where he was building machine learning models to predict post-surgical medical complications. He also worked as a researcher in Kyoto University Hospital studying neural activity markers of Schizophrenia using brain decoding and deep learning techniques. His doctoral work in Kyoto University focused on using deep learning models to understand robustness of human brain in recognizing degraded visual input.

    He also founded the Arabs in Neuroscience (AiN) not-for-profit, which is a grassroots organization that aims to enhance education and research among Arabic-speaking scientists and students all over the world. Through AiN, he runs an online introductory course in computational neuroscience. He is also a teaching assistant at the Computational Neuroscience Imbizo summer school and a member of The Africa I Know non-profit.

    Website: https://mabdelhack.github.io/

    Twitter handle: @mabdelhack

    Sources of funding

    This study was funded by grants for Daniel Felsky from The Koerner Family Foundation New Scientist Program, The Krembil Foundation, the Canadian Institutes of Health Research, the Canadian Foundation for Innovation, and the CAMH Discovery Fund. Author Mohamed Abdelhack was further supported by the CAMH womenmind postdoctoral fellowship.

    Source of text: Canadian Association for Neuroscience

    Scientific publication

    Abdelhack M, Zhukovsky P, Milic M, Harita S, Wainberg M, Tripathy SJ, Griffiths JD, Hill SL, Felsky D. Opposing brain signatures of sleep in task-based and resting-state conditions. Nat Commun. 2023 Dec 1;14(1):7927.

    https://rdcu.be/dEWTz